EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Recurrence Detection by Hybrid [ 18 F ] FDG ‐ PET in Advanced Head and Neck Squamous Cell Carcinoma

Oliver P Sutter iD, Alexander Maurer iD, Thomas M Stadler iD, Martin Lanzer iD, Martin W Huellner iD, Martina A Broglie iD

Head & Neck · 2025

DOI: 10.1002/hed.27997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Oliver P Sutter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Neoplasm Recurrence, Local, Positron-Emission Tomography, Head and Neck Neoplasms. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the clinical management of advanced stage head and neck squamous cell carcinoma, the use of hybrid [ 18 F]FDG‐PET imaging is well established. However, there is ongoing debate regarding the optimal frequency of hybrid PET scans to be included in follow‐up protocols, particularly if the initial post‐therapeutic scan is negative.

Methods

We conducted a single‐center 10‐year retrospective study involving all patients who underwent hybrid PET scans for the follow‐up of advanced stage head and neck cancer. A total of 285 patients were included.

Results

Out of 199 patients with a negative 3‐month hybrid PET, 15% subsequently developed a recurrence during further follow‐up. Notably, 90% of these recurrences were detected by hybrid PET.

Conclusion

Fifteen percent of patients with a negative 3‐month hybrid PET experienced a recurrence. Given that the majority of recurrences were detected by hybrid PET scans, there is a compelling argument for incorporating regular repetitive scans during follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Neoplasm Recurrence, LocalPositron-Emission TomographyHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellHumansRetrospective StudiesMaleFemaleMiddle AgedAgedRadiopharmaceuticalsAdultAged, 80 and overNeoplasm StagingFollow-Up Studies

Stichwörter der Autor:innen

head and neck neoplasmspositron emission tomographyrecurrenceretrospective studiessquamous cell carcinoma

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Department of Cranio-Maxillo-Facial and Oral Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Oliver P Sutter, Alexander Maurer, Thomas M Stadler, Martin Lanzer, Martin W Huellner, Martina A Broglie

Zitieren

APA

Sutter, O. P., Maurer, A., Stadler, T. M., Lanzer, M., Huellner, M. W., & Broglie, M. A. (2025). Recurrence Detection by Hybrid [ 18 F ] FDG ‐ PET in Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.27997

Vancouver

Sutter OP, Maurer A, Stadler TM, Lanzer M, Huellner MW, Broglie MA. Recurrence Detection by Hybrid [ 18 F ] FDG ‐ PET in Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. 2025. doi:10.1002/hed.27997

BibTeX
@article{Sutter2025,
  author = {Sutter, Oliver P and Maurer, Alexander and Stadler, Thomas M and Lanzer, Martin and Huellner, Martin W and Broglie, Martina A},
  title = {Recurrence Detection by Hybrid [ 18 F ] FDG ‐ PET in Advanced Head and Neck Squamous Cell Carcinoma},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27997}
}
Kostenlos starten →